Skip to main content
. 2012 Jul 11;2012(7):CD004425. doi: 10.1002/14651858.CD004425.pub6

10.4. Analysis.

10.4

Comparison 10 NOMAC 2 mg / E2 1.5 mg versus DRSP 3 mg / EE 30 µg, Outcome 4 Clinician assessment of worsening acne after cycle 13 (participants with acne at baseline).